Drug Approval | July 01, 2022
Lupin receives approval from USFDA for Paliperidone extended-release tablets
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
AstraZeneca also played a critical role in the global response to COVID-19.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
The company also raised Rs 270 crore investment from Temasek in 2019
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
The company dispatched the first batch of essential medicines worth US $ 30,000 to Ukraine through its embassy in New Delhi
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Subscribe To Our Newsletter & Stay Updated
